Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues.

about

Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues.

Item

http://www.wikidata.org/entity/Q51731233

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Synthesis and cytotoxic evalua ...... arylamide sorafenib analogues.

@en

Synthesis and cytotoxic evalua ...... arylamide sorafenib analogues.

@nl

type

Item

label

Synthesis and cytotoxic evalua ...... arylamide sorafenib analogues.

@en

Synthesis and cytotoxic evalua ...... arylamide sorafenib analogues.

@nl

prefLabel

Synthesis and cytotoxic evalua ...... arylamide sorafenib analogues.

@en

Synthesis and cytotoxic evalua ...... arylamide sorafenib analogues.

@nl

P1476

Synthesis and cytotoxic evalua ...... arylamide sorafenib analogues.

@en

P2093

Farshid Hassanzadeh

http://www.w3.org/2001/XMLSchema#string

Ghadamali Khodarahmi

http://www.w3.org/2001/XMLSchema#string

Mojtaba Khandan

http://www.w3.org/2001/XMLSchema#string

Sedighe Sadeghian-Rizi

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors

Biological evaluation of a novel sorafenib analogue, t-CUPM

Cytotoxicity and antiangiogenic effects of Rhus coriaria, Pistacia vera and Pistacia khinjuk oleoresin methanol extracts.

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.

BRAF kinase inhibitor exerts anti-tumor activity against breast cancer cells via inhibition of FGFR2.

Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.

Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.

Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit.

A combination of sorafenib and SC-43 is a synergistic SHP-1 agonist duo to advance hepatocellular carcinoma therapy.

P304

168-176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/1735-5362.223802

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29606971

http://www.w3.org/2001/XMLSchema#string

P932

5842488

http://www.w3.org/2001/XMLSchema#string